scorecardresearch
Tuesday, September 23, 2025
TopicCovishield

Topic: Covishield

First day of vaccination successful, over 1.65 lakh beneficiaries, says Health Ministry

The government said that and no case of post-inoculation hospitalisation has been reported so far.

India begins Covid ‘shots’ and Arnab Goswami’s WhatsApp ‘shock’

The best cartoons of the day, chosen by the editors at ThePrint.

Doubts over vaccines loom large on day one, govt officials say turnout to pick up eventually

In Delhi, 4,319 health workers were vaccinated, while in Maharashtra, 18,338 got the shots. In Karnataka, 22,256 health workers and in J&K, 2,000 got the vaccine Saturday.

Relief, excitement, jitters grip vaccine beneficiaries as India begins its immunisation drive

In Maharashtra, 28,500 frontline workers are expected to be vaccinated on the first day, while in UP, over 31,700 health workers are likely to get the shot. 

‘Credibility of scientists hurt’ — former AIIMS chiefs, other experts slam vaccine skeptics

Former AIIMS director T.D. Dogra, along with 48 other medical experts & scientists, has urged people to 'reject the manipulations' of those trying to 'defame' the scientific community. 

Brazil to be first country to get Covid vaccine from India, SII will supply 2 million doses

Covishield will reach Brazil next week. Modi govt had earlier this month authorised a deal between Brazilian govt & Serum Institute to supply the vaccine at a ‘special rate’.

Covishield emerges as first choice for states, Covaxin to be kept as a ‘buffer stock’

Delhi, Andhra, Telangana, Punjab will use Covishield, while Chhattisgarh has questioned the efficacy of Covaxin. Govt says vaccines were approved after they met the parameters.

First batch of Covishield vaccine leaves for Delhi from Pune’s Serum Institute facility

Besides Delhi, the vaccines will be dispatched to 12 other locations across the country in seven more flights by 10 am Tuesday.

First Covishield batch to be shipped tonight or tomorrow as India gears up for vaccine drive

Serum Institute of India will be selling each dose of Covishield at Rs 200 under the purchase agreement signed with Modi govt Monday for nearly one crore doses.

How India’s regulatory pitfalls helped Covishield and Covaxin get rapid approval

The lack of regulatory clarity coupled with lack of transparency from CDSCO raises questions on the safety and efficacy of the Covid-19 vaccine candidates.

On Camera

Should Goa share Mhadei waters? A living river can’t be divided like property

Asking Goa to give up 4% of a river’s flow to help parched districts seems reasonable, moral. But it masks a deeper ethical problem: who bears the burden of the ‘greater common good’?

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

India takes a relook at Russian Su-57, but not for its stealth. Here’s why

India exited the Indo-Russian FGFA programme in 2018. But now it might procure at least 2 squadrons of Su-57 aircraft from Russia and evaluate Russian proposal to manufacture them in India.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.